Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): Lessons from past programs and implications for the future

Analysis of the Bactericidal Response to an Experimental Neisseria meningitidis Vesicle Vaccine

(2012) Elizabeth E. Moran et al.   Clinical and Vaccine Immunology

Considerations for controlling invasive meningococcal disease in high income countries

(2012) Johan Holst et al.   VACCINE

Evolution of immune response against Neisseria meningitidis B:14:P1.7,16 before and after the outer membrane vesicle vaccine MenBvac

(2012) François Caron et al.   VACCINE

Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesicles

(2011) Xilian Bai et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

A combination recombinant protein and outer membrane vesicle vaccine against serogroup B meningococcal disease

(2011) Ee Lyn Su et al.   Expert Review of Vaccines

Eliminating Epidemic Group A Meningococcal Meningitis In Africa Through A New Vaccine

(2011) F. Marc LaForce et al.   HEALTH AFFAIRS

Meningococcal glycoconjugate vaccines

(2011) Roberto Gasparini et al.   Human vaccines & immunotherapeutics

Next-generation outer membrane vesicle vaccines againstNeisseria meningitidisbased on nontoxic LPS mutants

(2011) Peter van der Ley et al.   Human vaccines & immunotherapeutics

Reducing inequalities with vaccines: New Zealand's MeNZB vaccine initiative to control an epidemic

(2011) Diana Lennon et al.   JOURNAL OF PAEDIATRICS AND CHILD HEALTH

From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak

(2011) François Caron et al.   LANCET INFECTIOUS DISEASES

Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine in Africans

(2011) Samba O. Sow et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effectiveness of a vaccination programme for an epidemic of meningococcal B in New Zealand

(2011) Richard Arnold et al.   VACCINE

A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression

(2011) P.B. Keiser et al.   VACCINE

Phase I study of a Neisseria meningitidis liposomal vaccine containing purified outer membrane proteins and detoxified lipooligosaccharide

(2011) Wendell D. Zollinger et al.   VACCINE

Meningococcal Factor H Binding Proteins in Epidemic Strains from Africa: Implications for Vaccine Development

(2011) Rolando Pajon et al.   PLoS Neglected Tropical Diseases

Critical appraisal of a quadrivalent CRM197 conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo®) in the context of treatment and prevention of invasive disease

(2011) Michael Broeker et al.   Infection and Drug Resistance

Review of Meningococcal Group B Vaccines

(2010) Dan M. Granoff   CLINICAL INFECTIOUS DISEASES

Serogroup B meningococcal vaccines—an unfinished story

(2010) Manish Sadarangani et al.   LANCET INFECTIOUS DISEASES

Advances in the Development of Vaccines againstNeisseria meningitidis

(2010) Lionel K.K. Tan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines

(2010) J. Donnelly et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease

(2010) Han-Qing Jiang et al.   VACCINE

Fast Tracking the Vaccine Licensure Process to Control an Epidemic of Serogroup B Meningococcal Disease in New Zealand

(2009) Diana Lennon et al.   CLINICAL INFECTIOUS DISEASES

Challenges and progress in the development of a serogroup B meningococcal vaccine

(2009) Susan Lewis et al.   Expert Review of Vaccines

Sequence Diversity of the Factor H Binding Protein Vaccine Candidate in Epidemiologically Relevant Strains of Serogroup BNeisseria meningitidis

(2009) Ellen Murphy et al.   JOURNAL OF INFECTIOUS DISEASES

Immunogenicity and Tolerability in Infants of a New Zealand Epidemic Strain Meningococcal B Outer Membrane Vesicle Vaccine

(2009) Sharon H. Wong et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis

(2009) Johan Holst et al.   VACCINE

Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus

(2009) Stefania Bambini et al.   VACCINE

Phase II meningococcal B vesicle vaccine trial in New Zealand infants

(2008) C Jackson et al.   ARCHIVES OF DISEASE IN CHILDHOOD

Henoch-Schonlein purpura and meningococcal B vaccination

(2008) K Sexton et al.   ARCHIVES OF DISEASE IN CHILDHOOD

Use of an observational cohort study to estimate the effectiveness of the New Zealand group B meningococcal vaccine in children aged under 5 years

(2008) Y. Galloway et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Bactericidal Antibody Responses Elicited by a Meningococcal Outer Membrane Vesicle Vaccine with Overexpressed Factor H–Binding Protein and Genetically Attenuated Endotoxin

(2008) Oliver Koeberling et al.   JOURNAL OF INFECTIOUS DISEASES

Two centuries of meningococcal infection: from Vieusseux to the cellular and molecular basis of disease

(2008) A. L. de Souza et al.   JOURNAL OF MEDICAL MICROBIOLOGY

The risk of simple febrile seizures after immunisation with a new group B meningococcal vaccine, New Zealand

(2008) Paul Stehr-Green et al.   VACCINE

The Intensive Vaccines Monitoring Programme (IVMP): An electronic system to monitor vaccine safety in New Zealand

(2008) Michael V. Tatley et al.   VACCINE

MeNZB™ vaccine and epidemic control: When do you stop vaccinating?

(2008) Belinda J. Loring et al.   VACCINE